During the past decade, Csongrad Megyei Onkormanyzat Mellkasi Betegsegek Szakkorhaza conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 9 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Csongrad Megyei Onkormanyzat Mellkasi Betegsegek Szakkorhaza" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Aerovance, Inc." with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Csongrad Megyei Onkormanyzat Mellkasi Betegsegek Szakkorhaza" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Csongrad Megyei Onkormanyzat Mellkasi Betegsegek Szakkorhaza" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Non-small Cell Lung Cancer" (2 trials), "Asthma" (1 trials), "Carcinoma Non-small Cell Lung Cancer Stage IIIA" (1 trials) and "Carcinoma Non-small Cell Lung Cancer Stage IIIB" (1 trials). Many other conditions were trialed in "Csongrad Megyei Onkormanyzat Mellkasi Betegsegek Szakkorhaza" in a lesser frequency.

Most popular intervention types in "Csongrad Megyei Onkormanyzat Mellkasi Betegsegek Szakkorhaza" are "Drug" (12 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (4 trials), "Paclitaxel" (4 trials), "Placebo" (3 trials), "Bevacizumab" (2 trials) and "afatinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Csongrad Megyei Onkormanyzat Mellkasi Betegsegek Szakkorhaza" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Csongrad Megyei Onkormanyzat Mellkasi Betegsegek Szakkorhaza". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Csongrad Megyei Onkormanyzat Mellkasi Betegsegek Szakkorhaza, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Csongrad Megyei Onkormanyzat Mellkasi Betegsegek Szakkorhaza, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".